Hepariniserte overflater

D.01. Øvrum, E, Åm Holen E, Tangen G, Brosstad F, Abdelnoor M, Ringdal MAL, Øystese R, Istad R. 
Completely heparinized cardiopulmonary bypass and reduced systemic heparin; clinical and hemostatic effects . 
Ann Thorac Surg 1995; 60: 365-71.
Abstract

D.02. Øvrum E, Fosse E, Mollnes TE, Åm Holen E, Tangen G, Abdelnoor M, Ringdal MAR, Øystese R, Venge P. 
Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation . 
Europ J Cardio-thorac Surg 1996; 10: 54-60.

D.03. Øvrum E, Mollnes TE, Fosse E, Åm Holen E, Tangen G, Abdelnoor M, Ringdal MAL, Øystese R, Venge, P. 
Complement and granulocyte activation in two different types of heparinized extracorporeal circuits . 
J Thorac Cardiovasc Surg 1995; 110: 1623-32.
Abstract

D.04. Øvrum E, Brosstad F, Åm Holen E, Tangen G, Abdelnoor M, Øystese R. 
Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis . 
Europ J Cardio-thorac Surg 1996; 10: 54-60.

D.05. Øvrum E, Mollnes TE, Fosse E, Åm Holen E, Tangen G, Ringdal MAL, Videm V. 
High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes . 
Ann Thorac Surg 1995; 60: 1755-61.
Abstract

D.06. Øvrum E, Brosstad F, Åm Holen E, Tangen G, Abdelnoor M. 
Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass . 
Circulation 1995; 92: 2579-84.
Abstract

D.07. Øvrum E. 
Cardiopulmonary bypass with heparinized circuits. Clinical experience with two different systems . 
Thesis at University of Oslo 1996;
ISBN 82-7722-045-6

D.08. Øvrum E. 
Eosinophil granulocyte activation and heparin-coated cardiopulmonary bypass (letter) . 
Ann Thorac Surg 1996; 61: 1038-9.

D.09. Øvrum E, Åm Holen E, Tangen G, Ringdal MAL. 
Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance . 
Ann Thorac Surg 1996; 62: 1128-33.
Abstract

D.10. Barstad RM, Øvrum E, Ringdal MAL, Øystese R, Hamers MJAG, Veiby OP, Rolfsen T, Stephens RW, Sakariassen KS. 
Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit . 
Br J Haematol 1996; 94: 517-25.
Abstract

D.11. Øvrum E. Videm V. Reply to Ranucci M. 
Antithrombin III, leukocyte activation, and low systemic heparinization . 
Ann Thorac Surg 1997; 63: 1211-12.

D.12. Baksaas ST, Flom-Halvorsen HI, Øvrum E, Videm V, MollnesTE, Brosstad F, Svennevig JL. 
Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery . 
Perfusion 1999; 14: 107-17.

D.13. Øvrum E, Tangen G, Øystese R, Ringdal MAL, Istad R.. 
Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations . 
J Thorac Cardiovasc Surg 2001; 121: 324-30.

D.14. Flom-Halvorsen HI, Øvrum E, Brosstad F, Tangen G, Ringdal MAL, Øystese R. . 
Effects of two differently heparin-coated extracorporal circuits on markers for brain and myocardial dysfunction.   
Perfusion  2002; 17: 339-40.

D15. Øvrum E, Tangen G, Tølløfsrud S, Ringdal MAL, Istad R. Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time CABG. Ann Thorac Surg 2003;76:1144-8.

D.16. Øvrum E, Tangen G, Øystese R, Ringdal MAL, Istad R. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery. J Card Surg 2003;18:140-6.

D.17. Hanne I Flom Halvorsen. Hemostatic activation and inflammatory response during and after cardiopulmonary bypass. Thesis at University of Oslo, 2005. ISBN: 82-8072-634-9.